Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 03, 2025 10:30 ET | Source: Research and Markets

Bio-Detection Business Research Report 2025: Global Market to Reach $33.9 Billion by 2030, Driven by Expansion of Bio-Surveillance Systems in Homeland Security and Defense, & Growth of Lab-on-a-Chip

Dublin, April 03, 2025 (GLOBE NEWSWIRE) -- The "Bio-Detection - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Bio-Detection was...
April 12, 2016 08:30 ET | Source: PositiveID Corporation

PositiveID Reports 2015 Revenue of $2.9 Million, Up 211% Year over Year

DELRAY BEACH, Fla., April 12, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced its...
August 17, 2015 08:30 ET | Source: PositiveID Corporation

PositiveID Enters Into Strategic Financing for $2.4 Million

Fixed-Price Financing Struck at a Premium to Market Proceeds to Be Used to Develop Field-Testable Units of PositiveID’s Firefly Dx Pathogen Detection System for Point-Of-Need Diagnostics DELRAY...
February 20, 2013 08:30 ET | Source: PositiveID Corporation

PositiveID Corporation Announces License of iglucose Technology for Up to $2 Million

DELRAY BEACH, Fla., Feb. 20, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced it...
March 20, 2012 08:30 ET | Source: PositiveID Corporation

PositiveID Corporation Awarded U.S. Patent No. 8,133,451 for First-of-Its-Kind Detection System for Molecular Biological Diagnostics

DELRAY BEACH, Fla., March 20, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as...
August 02, 2011 16:30 ET | Source: PositiveID Corporation

PositiveID Corporation Receives an Additional Key Patent for Fieldable Biological Detection

DELRAY BEACH, Fla., Aug. 2, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical diagnostics...
July 20, 2011 08:30 ET | Source: PositiveID Corporation

PositiveID Corporation Awarded Key Patent for Sample Prep of DNA and RNA

Intellectual Property to Support Sales and Licensing of Diagnostic Products Sample Prep Technology Can be Used in the Field or Clinical Environment to Quickly Obtain and Purify Samples for...